BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 26096269)

  • 1. Impact of the United Kingdom national bowel cancer awareness campaigns 2012 on colorectal cancer services and patient survival.
    Khong TL; Naik K; Sivakumar R; Shah S
    Colorectal Dis; 2015 Dec; 17(12):1055-61. PubMed ID: 26096269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of the United kingdom national bowel cancer awareness campaign on colorectal services.
    Pande R; Leung E; McCullough P; Smith S; Harmston C
    Dis Colon Rectum; 2014 Jan; 57(1):70-5. PubMed ID: 24316948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 'Be Clear on Cancer': the impact of the UK National Bowel Cancer Awareness Campaign.
    Peacock O; Clayton S; Atkinson F; Tierney GM; Lund JN
    Colorectal Dis; 2013 Aug; 15(8):963-7. PubMed ID: 23656572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The bowel cancer awareness campaign 'Be Clear on Cancer': sustained increased pressure on resources and over-accessed by higher social grades with no increase in cancer detected.
    Hall SJ; Peacock JD; Cochrane LA; Peacock O; Tierney GM; Tou SI; Lund JN
    Colorectal Dis; 2016 Feb; 18(2):195-9. PubMed ID: 26333198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Did the 'Be Clear on Bowel Cancer' public awareness campaign pilot result in a higher rate of cancer detection?
    Bethune R; Marshall MJ; Mitchell SJ; Oppong C; Cartmel MT; Arumugam PJ; Gee AS; Daniels IR
    Postgrad Med J; 2013 Jul; 89(1053):390-3. PubMed ID: 23572594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 2-week wait referral system does not improve 5-year colorectal cancer survival.
    Zafar A; Mak T; Whinnie S; Chapman MA
    Colorectal Dis; 2012 Apr; 14(4):e177-80. PubMed ID: 21920007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The "two-week wait" referral pathway is not associated with improved survival for patients with colorectal cancer.
    Aslam MI; Chaudhri S; Singh B; Jameson JS
    Int J Surg; 2017 Jul; 43():181-185. PubMed ID: 28600231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association between referral source and outcome in patients with colorectal cancer.
    Schneider C; Bevis PM; Durdey P; Thomas MG; Sylvester PA; Longman RJ
    Surgeon; 2013 Jun; 11(3):141-6. PubMed ID: 23238513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary care referral practice, variability and socio-economic deprivation in colorectal cancer.
    Borowski DW; Cawkwell S; Zaidi SM; Toward M; Maguire N; Gill TS
    Colorectal Dis; 2016 Nov; 18(11):1072-1079. PubMed ID: 27110954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in urgent referrals for suspected colorectal cancer: an increase in quantity, but not in quality.
    Vulliamy P; McCluney S; Raouf S; Banerjee S
    Ann R Coll Surg Engl; 2016 Nov; 98(8):564-567. PubMed ID: 27551894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The 2-week wait service: a UK tertiary colorectal centre's experience in the early identification of colorectal cancer.
    Patel RK; Sayers AE; Seedat S; Altayeb T; Hunter IA
    Eur J Gastroenterol Hepatol; 2014 Dec; 26(12):1408-14. PubMed ID: 25244412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of the United kingdom national bowel cancer awareness campaign on colorectal services.
    Bhalla A; Peacock O; Lund JN
    Dis Colon Rectum; 2015 Jun; 58(6):e393-4. PubMed ID: 25944440
    [No Abstract]   [Full Text] [Related]  

  • 13. Prioritisation by FIT to mitigate the impact of delays in the 2-week wait colorectal cancer referral pathway during the COVID-19 pandemic: a UK modelling study.
    Loveday C; Sud A; Jones ME; Broggio J; Scott S; Gronthound F; Torr B; Garrett A; Nicol DL; Jhanji S; Boyce SA; Williams M; Barry C; Riboli E; Kipps E; McFerran E; Muller DC; Lyratzopoulos G; Lawler M; Abulafi M; Houlston RS; Turnbull C
    Gut; 2021 Jun; 70(6):1053-1060. PubMed ID: 32855306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Volume-outcome relationship for colorectal cancer in primary care: a prospective cohort study.
    Borowski DW; Cawkwell S; Zaidi SMA; Toward M; Maguire N; Gill TS
    Int J Health Care Qual Assur; 2017 Jun; 30(5):398-409. PubMed ID: 28574322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effectiveness of the '2-week wait' referral service for colorectal cancer.
    Leung E; Grainger J; Bandla N; Wong L
    Int J Clin Pract; 2010 Nov; 64(12):1671-4. PubMed ID: 20946272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Change in public awareness of symptoms and perceived barriers to seeing a doctor following Be Clear on Cancer campaigns in England.
    Power E; Wardle J
    Br J Cancer; 2015 Mar; 112 Suppl 1(Suppl 1):S22-6. PubMed ID: 25734386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An innovative solution to raise public awareness using a mobile colorectal clinic - The 'bowel bus'.
    Naguib N; Lewis M; Iredale R; Pugh R; Haray PN
    Int J Surg; 2017 Mar; 39():188-191. PubMed ID: 28161528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The "two-week wait" referral pathway allows prompt treatment but does not improve outcome for patients with oesophago-gastric cancer.
    Sharpe D; Williams RN; Ubhi SS; Sutton CD; Bowrey DJ
    Eur J Surg Oncol; 2010 Oct; 36(10):977-81. PubMed ID: 20702059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repeat 2-week wait referrals for colorectal cancer.
    Vaughan-Shaw PG; Cutting JE; Borley NR; Wheeler JM
    Colorectal Dis; 2013 Mar; 15(3):292-7. PubMed ID: 22776207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two-week wait symptoms are prevalent in screened patients with a positive faecal occult blood test but do not predict cancer.
    Vaughan-Shaw PG; Cutting J; Borley N; Brooklyn T; Wheeler JM
    Colorectal Dis; 2014 Jan; 16(1):40-7. PubMed ID: 24103034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.